Aims/hypothesis Chronic non-healing wounds are a common complication of diabetes. Prolonged inflammation and decreased matrix accumulation may contribute. Connective tissue growth factor (CTGF) is induced during normal wound healing, but its regulation in diabetic wounds is unknown. We developed a primate model for the study of in vivo wound healing in baboons with long diabetes duration. Methods Drum implants were placed subcutaneously into thighs of diabetic and non-diabetic control baboons. After 2 and 4 weeks the skin incision sites were removed for measurement of breaking strength and epithelial thickness.
Introduction
Diabetes is one of the leading causes of impaired wound healing, with many amputations performed each year as a result of chronic, non-healing wounds [1] . These wounds have been associated with prolonged and dysregulated levels of inflammatory cells, such as neutrophils and macrophages [2, 3] . Other studies have shown that the degradative capacity of chronic wounds is increased whilst growth factor levels are reduced [4, 5] , collectively contributing to impaired granulation tissue formation and delayed epithelial closure in diabetic wounds.
For normal wound healing to progress, the balance between extracellular matrix (ECM) synthesis and its degradation is important, as is the induction of new blood vessels [5] . These processes are tightly regulated by growth factors such as platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF) and connective tissue growth factor (CTGF) and by the matrix-degrading enzymes known as matrix metalloproteinases (MMPs). Compared with normal wound healing processes, wound healing in patients with diabetes results in decreased concentrations of PDGF and VEGF proteins in wound tissue [6, 7] ; however, the effect of diabetes on CTGF in wounds in skin and granulation tissue has not been studied.
CTGF is a profibrotic growth factor in the CCN family of proteins which is induced during normal cutaneous wound healing [8] . It has a variety of actions, including induction of fibroblast proliferation, migration, adhesion and ECM formation [8] . CTGF is also produced by cultured endothelial cells [9] and causes proliferation, migration and adhesion of vascular endothelial cells [10, 11] . We have previously shown, albeit in renal mesenchymal cells, that CTGF can upregulate levels of the specific MMP inhibitor TIMP-1 [12] .
Wound healing models using implantation of subcutaneous devices have been developed in a variety of animals, including rats, dogs and humans [13] [14] [15] . These models allow the collection of cells, fluid and wound tissue, although typically they have only been short-term, from days up to a couple of weeks. The most common collection device has been the sponge [13, 14, 16] , where cells invade and lay down collagen. Other studies have involved insertion of porous cylinders, most commonly the HuntSchilling stainless steel mesh cylinder [17] . These cylinders have been useful for the study of wound repair as they induce a response that exhibits the classic phases of inflammation, connective tissue infiltration, neovascularisation and matrix deposition [15, 18] . Temporal changes in inflammatory cell infiltration, matrix deposition and growth factor production can also be measured.
We have previously reported changes due to diabetes complications in our established non-human primate model of type 1 diabetes [19] [20] [21] . This animal model of streptozotocin-induced diabetes has been well characterised [22, 23] and develops complications comparable with those occurring in human diabetes [19, 21] . Animals have diabetes duration of greater than 10 years. In the present work we examined the effects of diabetes on wound healing in these primates for the first time, by implanting sterile plastic drums subcutaneously. This novel wound model allows the collection of granulation tissue and wound fluid from these drums in the absence of external contamination. Epithelial changes and tensile strength of the healed incision site can also be assessed by excising the skin at the time of removal of the subcutaneous drums. We hypothesised that, compared with the age-matched cohort of non-diabetes controls, diabetic animals would show abnormal regulation of: cutaneous healing, inflammatory cell profiles, granulation tissue formation and tissue CTGF.
Methods

Baboon model
The induction and maintenance of this colony of long-term diabetic and control baboons has been described elsewhere [22] . Briefly, male baboons were made diabetic at 2.5 years of age by intravenous injection of streptozotocin (65 mg/kg in 0.1 mol/l citrate buffer, pH 4.5). Animals were maintained on once daily injections of a combination of short-and long-acting insulin (Humulin R and Humulin NPH; Eli Lilly, West Ryde, NSW, Australia) at an average dose of 4 U/kg/day with adjustments made at intervals of 3 months according to the HbA 1c level. Animal details at the time of the study are shown in Table 1 . All work was approved by the Sydney South West Area Health Service Animal Ethics Committee under the guidelines of National Health and Medical Research Council of Australia for use of non-human primates in research.
To implant and remove drums, baboons were anaesthetised using a combination of ketamine (6 mg/kg; Ketamil; Troy Laboratories, Smithfield, NSW, Australia) and medetomidine hydrochloride (60 μg/kg; Domitor; Novartis Animal Health, North Ryde, NSW, Australia). Effects of medetomidine were reversed by atipamezole hydrochloride (300 μg/kg; Antisedan; Novartis Animal Health, Australia).
Drum implants (Fig. 1a) were 5×15 mm (depth × diameter) polystyrene Netwells with fine polyester 74 µm mesh on the top and bottom surfaces (Corning Life Sciences, Santa Clara, CA, USA). Implants were plasmasterilised and inserted surgically, two drums per thigh via a 3 cm skin incision. Incisions (Fig. 1b) were closed using subcuticular absorbable sutures (Polysorb; Tyco Healthcare, Norwalk, CT, USA). Antibiotic cover was provided by an injection of amoxicillin trihydrate on alternate days (10 mg/kg; Betamox LA; Norbrook Laboratories, Tullamarine, VIC, Australia), three in total. After 2 and 4 weeks, the healed, sutured skin incision site was excised with 10 mm skin margins, and stored at −80°C for later measurement of wound breaking strength and the thickness of the epithelial incision site. By the time of skin excision, all incision sites had healed in all animals. Drums (n=2 per time point) were then removed and wound fluid was aspirated from within the chamber for later analysis. The granulation tissue from within the drum was divided and fixed in 10% formalin for histological analysis or snap-frozen for later analysis.
Incision site analysis
For the measurement of wound breaking strength, healed sutured skin incision sites were removed from storage and cut into shape using an aluminium template (Fig. 1c) . Width, length and thickness of skin pieces were measured using callipers. Tensile strength was determined at room temperature. Tissue ends were placed in the jaws of an Elf 3400 Tensiometer (BOSE EnduraTec, Minnetonka, MN, USA). Load and displacement until the time of skin rupture at the healed incision site were obtained using a 45 N load at a cross-head speed of 10 mm/min. Cross-sectional area was determined from original skin thickness measurements and values were used to calculate stress and strain and Young's modulus (tensile strength).
As a marker of remodelling, the epidermal thickness of the healed incision site was measured in sections stained with haematoxylin and eosin (Image J; National Institutes of Health, Bethesda, MD, USA), at five regular points along the suture line of the healed epidermis and at five points in unwounded skin. Values were averaged and results expressed as the percentage increase compared with unwounded skin.
Histopathology and immunohistochemistry
Formalin-fixed paraffin-embedded sections ( [24] ) and TIMP-1 (1:400; Cat. no. 770, Chemicon International) was by immunohistochemistry using the [25] and the resulting antiserum was confirmed using a previously described method [21] to specifically detect CTGF in baboon renal tissue by immunohistochemistry (not shown).
Quantification of staining
Sections stained with Masson's trichrome were examined microscopically and amounts of granulation tissue present were determined using Image Pro Plus (Media Cybernetics, Silver Spring, MD, USA). The amount of granulation tissue was expressed as a percentage of total tissue area obtained from three sections 50 µm apart. Sections stained for CTGF, TIMP-1, fibronectin and collagen IV were scored from 0 to 3 by two independent observers blinded to tissue source, 0 indicating no staining and 3 intense staining. Macrophages and neutrophils were counted at ×100 magnification in 20 fields using two sections 50 μm apart and results were averaged. Lumen areas of blood vessels were measured at ×20 magnification using Axiovision 4 (Carl Zeiss Vision). All vessel lumens in three separate sections per animal were measured.
Tissue RNA isolation and real-time quantitative PCR Pure total RNA was isolated freshly from wound tissue (~100 mg) and prepared as cDNA, as described previously [12, 24] . Primers were designed against highly conserved regions of multiple species including >99% homology with human amplicons. Primer sequences are shown in the Electronic supplementary material (ESM) Table 1 . Thermal cycles for amplification were as follows: 2 min at 50°C, 5 min at 95°C and 45 cycles of 95°C for 10 s, 55°C for 20 s and 72°C for 20 s. The delta/delta method was used to compare gene expression between animals with diabetes and non-diabetic controls. Results were corrected for 36B4 (also known as RPLP0) as housekeeper.
Analysis of whole wound tissue CTGF protein was extracted from wound tissue using RIPA buffer. Whole tissue lysate was loaded (50 μg per lane) onto SDS-PAGE gels under reducing conditions then transferred onto polyvinylidene fluoride membranes and assessed by western immunoblotting using anti-CTGF primary antibody (197, 1:1,000) as described previously [26] . Immunoreactive band intensities were assessed by Image Analysis, corrected for the housekeeper loading control, GAPDH.
Degradation of rhCTGF by wound fluid
Wound fluid samples (5 µl from each baboon) were pooled into control and diabetic groups. The rhCTGF was produced as described previously [12, 26] . Pooled wound fluid (15 µl) was mixed with either PBS (15 µl) or rhCTGF (15 µl), each containing 0.1% BSA (Sigma). In other samples, rhCTGF (15 µl) alone was incubated with PBS containing 0.1% BSA (15 µl). All samples (total 30 µl), except one rhCTGF sample, as indicated in Fig. 8b , were incubated at 37°C for 24 h and then loaded onto a SDS-PAGE gradient gel. The effect of wound fluid on rhCTGF degradation was analysed by western immunoblotting against CTGF using 197 antibody [25] . Total immunoreactivity was determined by Image Analysis and expressed as individual molecular mass band intensities and the sum of all immunoreactive bands.
Statistical analysis
Differences between groups were analysed by ANOVA using NCSS (Number Cruncher Statistical Analysis, UT, USA), except for blood vessel lumen size, for which differences between the groups were analysed using a two-sample t test c H-shaped template used to excise skin of standard dimensions and containing the healed cutaneous incision site at 2 or 4 weeks assuming equal variance. All data are mean±SD and values of p<0.05 were considered significant.
Results
Animal characteristics
Physical characteristics of the baboons at the time of tissue sampling are shown in Table 1 . The diabetic baboons had lower body weight, higher HbA 1c and higher blood glucose levels than control animals and their diabetes duration was more than 10 years.
Effect of diabetes on the wound breaking strength and incision site epidermal thickness Young's modulus was greater in the diabetic baboons compared with the control baboons ( Table 2 , p<0.05), indicating the healed incision site was stiffer and less extendable in the diabetic baboons. In control animals the epidermal thickness at the incision site was significantly greater at 2 weeks than 4 weeks. In contrast, this decrease in thickness with time was not observed in the diabetic animals, in which the thickness was significantly greater than in controls at 4 weeks (Fig. 2 , Table 2 ).
Effect of diabetes on granulation tissue formation, inflammatory cell response, CTGF and TIMP-1 immunostaining
Formation of granulation tissue After 4 weeks there was less granulation tissue in the drums of the diabetic baboons compared with controls ( Fig. 3a-d , quantified in Fig. 4a ). Under H&E staining at higher magnification the tissue also appeared coarser, less well formed and more disorganised in diabetic animals than in controls ( Fig. 3e-h ). Fibronectin and collagen IV staining appeared darker in control than diabetic tissue, as seen at 4 weeks (Fig. 3i, j and k, l respectively) . There was a trend for fewer blood vessels in diabetic tissue (Fig. 4b ). Blood vessel lumens at 4 weeks were significantly larger (control 610±218 pixels, diabetic, 1263±389 pixels; p=0.01), and the vessel walls appeared to be thinner (Fig. 4c,  d ) in tissue from the diabetic baboons. The α-SMA staining in control and diabetic animals was mainly localised to endothelial cells rather than fibroblasts (Fig. 4e, f) .
Pattern of inflammatory cell response The pattern of change in inflammatory cell infiltrate appeared to be different between the groups. In control animals the neutrophil and macrophage numbers decreased between the 2-and 4-week time points (Fig. 5a and b respectively). This decrease was not observed in the diabetic animals and the macrophage number at 2 weeks was lower than in controls at the same time point (p<0.05) (Fig. 5b) . Fig. 1) . A similar pattern was observed for TIMP-1 protein levels, differences failing to reach statistical significance (Figs 6e-h and 7b). There was no difference in CTGF mRNA levels in the tissue (Fig. 7a) , suggesting post-transcriptional regulation and the possible compartmentalisation of CTGF across wound tissue and fluid. The TIMP-1 (also known as TIMP1) mRNA levels were also not different between groups (Fig. 7d) . Interestingly, reduced macrophage number at 2 weeks in diabetic tissue correlated positively with a low level of wound tissue CTGF protein at 4 weeks (r=0.65, p<0.05). As a reference, CTGF immunoperoxidase staining in control and diabetic skin from unwounded baboons is shown in ESM Fig. 2 , indicating minimal CTGF signal in hair follicles and basal epidermal cells and only weak staining in the unwounded dermal tissue. There were no clear differences between control and diabetic baboons in unwounded skin.
CTGF and TIMP-1 detection
The effect of diabetes on CTGF levels in whole tissue lysate was investigated by western immunoblotting. The relative amount of~26 kDa CTGF protein fragment in tissue from the diabetic baboons at 4 weeks was significantly greater than that in control tissue (Fig. 8a, Table 3 ). The same immunoblot profile seen for the 197 primary anti-CTGF antibody was observed using the 196 anti-CTGF antibody (not shown). When combined with the CTGF immunohistochemistry result, these whole tissue lysate data suggest that in diabetic animals CTGF may be redistributed from granulation tissue into other sites, including wound fluid.
To determine whether wound fluid from diabetic animals may be more likely to degrade exogenously added CTGF, pooled wound fluids from control and diabetic baboons were incubated with rhCTGF and the effect on the amount of CTGF and its disappearance was examined by western immunoblotting (Fig. 8b) . For analysis, the band intensities were measured and summed (Table 4) . Incubation of rhCTGF with wound fluid collected from control and diabetic baboons at 2 weeks resulted in~40% and 45% reduction in total immunoreactivity, respectively. A different pattern was observed in pooled wound fluids obtained Haematoxylin and eosin stain (e-g) of tissue from control (e, g) and diabetic baboons (f, h) at 2 weeks (e, f) and 4 weeks (g, h). The diabetic tissue appeared looser, less well formed and less organised than control tissue. Fibronectin staining (i, j) of tissue from control (i) and diabetic (j) baboons at 4 weeks. Collagen IV staining (k, l) of tissue from control (k) and diabetic (l) baboon tissue at 4 weeks. Unless otherwise stated, magnification is ×40; scale bar, 100 µm at 4 weeks, in that the total decrease in immunoreactivity was only 10% for control fluid and remained higher in fluids from diabetic baboons (30% loss). In particular, the lower molecular mass fragments (~17 and 12 kDa) were reduced in intensity when rhCTGF was co-incubated with diabetic compared with control fluid. While this profile of change was also observed in a second independent experiment (not shown), statistically significant differences in relative CTGF fragment amounts in control and diabetic animals were not observed across both experiments combined (not shown).
Discussion
The novel findings of this study are that a wound healing model in diabetic baboons has been developed which demonstrates abnormalities in the wound microenvironment. Specifically, granulation tissue formation was reduced in diabetic animal wounds compared with wounds in control animals. In addition, for the first time in diabetic wounds, CTGF has been shown to be dysregulated. This subacute model with a duration of 4 weeks will be useful in testing methods to improve wound healing in diabetes.
Wound healing is a fibroproliferative response that aims to replace damaged or lost tissue. It is a complex phenomenon involving processes such as recruitment of inflammatory cells, proliferation and migration of parenchymal and connective tissue cells, then angiogenesis and Control animal data are shown as black diamonds and diabetic animal data as white triangles. a Neutrophil number in control tissue had decreased significantly at 4 weeks compared with 2 weeks (*p<0.05). Diabetic tissue had a non-significant trend to fewer neutrophils at 2 weeks compared with controls at 2 weeks. b Macrophage number was markedly increased in the control tissue at 2 weeks compared with diabetic tissue at 2 weeks (*p<0.05). Macrophage number at 4 weeks was significantly reduced in control tissue compared with control tissue at 2 weeks (*p<0.05), whereas the level did not change in diabetic tissue at 4 weeks, compared with control tissue at 2 weeks. Thus, in diabetic tissue there was no peak influx of neutrophils or macrophages at either time point granulation tissue formation [27] . Animal models of wounding provide a method to study the complex interactions that occur in living tissue [28] . There are two types of in vivo wound healing models, one involving the creation of open wounds in the skin and the other the accumulation of granulation tissue in a cylinder or sponge placed subcutaneously. Each type of model has advantages and disadvantages. The open model can be used to visualise the closure of a wound and includes epithelial changes, but it also has the potential for infection. More importantly, open wounds in different species heal in different ways. In humans and pigs this is mainly by the formation of granulation tissue followed by re-epithelialisation [29] , whereas rodents and other mammals heal mainly by contraction of wound edges [30] . Therefore, the epithelial changes seen in open wound models in rodents do not necessarily translate to changes seen in human wounds. The baboon model of wound healing in this work is designed to enable analysis of both the epithelial changes that occur after an incisional injury to the skin, and to mimic the granulation tissue that typically forms during wound healing [15] .
The main components of skin that affect its mechanical behaviour are elastin fibres, collagen fibres and the ground substance [31] . Pathological changes in the skin often correlate with changes in tissue elasticity [32] . The process of wound healing in the elderly is altered and delayed [33] , and increasing age has been shown to result in increased skin stiffness [34] . In our baboon model we demonstrate a similar effect of increased stiffness in the diabetic healed skin incision site, which is likely to be due to increased cross-linking of skin collagen.
In the healing of cutaneous wounds, epidermal thickness initially increases above that seen in unwounded skin and . b There was no difference between animal groups in the CTGF mRNA level at either time point. c TIMP-1 protein determined by immunohistochemistry. There was no difference between animal groups in TIMP-1 protein at 2 or 4 weeks. d There was no difference between animal groups in TIMP-1 mRNA level at either time point. For the mRNA species measured, 36B4 was the reference housekeeper gene. In a and c, control animal data are shown as black diamonds and diabetic animal data as white triangles. In b and d, control animal data are shown as black columns and diabetic animal data as shaded columns then returns towards normal [30] . This was observed in the examination of the skin incision sites in the control animals at 2 then 4 weeks. The diabetic animals also showed an increase in epidermal thickness at 2 weeks, although the lack of reduction in thickness at 4 weeks suggests that epidermal wound healing is delayed in diabetic animals.
The wound microenvironment in diabetes is altered in many ways, including abnormal cellular infiltration and impaired vascular formation [35] . There is delayed and prolonged inflammation with impaired angiogenesis [36] , as well as defective macrophage function and decreased collagen synthesis [35] . Neutrophil infiltration appears to be delayed and protracted in diabetes, while the role of the macrophage in the transition from the inflammatory to the proliferating phase of a healing wound is impaired [5] . Our model displays these findings with a delayed influx of both neutrophils and macrophages and reduced granulation tissue. The increase in vessel lumen size, approximately twofold, in diabetic tissue at 4 weeks was a striking and novel finding, as was the observed reduction in vessel wall thickness. The functional significance of this is not clear and further studies are required to assess vessel dysfunction, including leakiness.
Because of their early arrival at the wound site and phagocytosis of bacteria and removal of tissue debris, neutrophils are considered to have a role confined to host defence [37] . It is recognised that inflammatory cells are essential for normal wound healing; neutrophil-deficient mice demonstrate impaired wound healing [38] . One advantage of this baboon model is the absence of infection, so the inflammatory cells present are part of the process of granulation tissue formation, not removal of bacteria. This inflammatory response is important but it must be regulated to prevent its activity from becoming excessive [39] , as excessive inflammatory cells and mediators result in imbalances in wound proteases and their inhibitors, leading to inhibition of matrix synthesis and remodelling [40] . In this model, in the diabetic tissue neutrophil infiltrates did not decrease as consistently as observed in the control tissue 4 weeks after drum insertion.
Macrophages are important in wound healing as they secrete growth factors and cytokines that attract fibroblasts and endothelial cells as well as MMPs to remodel the granulation tissue [2, 41] . It is important that the macrophages present at the time release a growth factor that is required at that stage of healing, as this will vary throughout the course of the wound healing process [42] . In this study we show a marked reduction in macrophage infiltration into the site, an effect that was not corrected at the 4 week time point. Moreover, we found that the lack of macrophage infiltration at 2 weeks correlated with less tissue CTGF present by immunohistochemical staining at 4 weeks, suggesting a mechanistic link between the two processes, although intervention studies would be required to assess causality. Early studies described the functions of CTGF as connective tissue cell proliferation, differentiation, chemotaxis and adhesion [8, 9, 43] . CTGF is synthesised by fibroblasts and stimulates the proliferation and chemotaxis of these cells as well as the production of various ECM components in fibroblast cultures, including collagen I, fibronectin and collagen IV [44, 45] . CTGF is produced at increased levels during normal wound repair [8] and at sites of fibrogenesis [11, 45] . CTGF is normally produced in keratinocytes in the epidermis [46] , and in cell culture [47] , so it may have a role in the remodelling of the epidermis after wounding. In a rhesus monkey model of burns, CTGF accelerated wound healing including epithelial closure [48] . CTGF is also a chemotactic factor for macrophages [49] and therefore it may also potentiate wound healing.
The new findings in the present work relating to CTGF demonstrate dysregulation in the presence of diabetes. Others have reported that in normal wound healing CTGF is induced [8] , and we also found that CTGF was significantly increased in granulation tissue with time in the non-diabetic control animal wounds (Fig. 7a) . In contrast, in unwounded skin CTGF levels were relatively low (ESM Fig. 2 ), also as reported by others [8] . In the present study, compared with granulation tissue from control animals, we observed a lesser amount of CTGF protein in the diabetic granulation tissue by immunohistochemistry at 4 weeks. In contrast, the carboxy-terminal 26 kDa CTGF fragment was increased in whole tissue lysate from diabetic wounds. CTGF mRNA levels were not different between control and diabetic animal tissues. We also observed an overall reduction in the total amount of immunoreactive CTGF when exogenous rhCTGF was added to the pooled diabetic wound fluid after 24 h of incubation at 37°C. This latter finding was not statistically significant and it may be that small sample size, pooled wound fluid and/or the limited incubation times studied may have contributed to detection of trends only. Collectively, these data suggest that CTGF is compartmentally changed post-translationally in diabetic tissue: it is lesser in amount in granulation tissue, and may be more readily released into and cleared from wound fluid. The determination of whether CTGF has a role in improving wound healing in diabetes studies would require CTGF therapy as protein and/or gene expression systems, probably as a local application.
In humans and animal models where it has been studied, steady-state CTGF mRNA and/or protein is upregulated in many diabetic tissues, as previously summarised [50] . We have found that CTGF is increased in kidney tissue in diabetic baboons and that the elevated renal CTGF protein levels predict subsequent pathological albuminuria [21] . In contrast, by using the same animals that were studied in the renal series, in the present work CTGF mRNA was not increased in the diabetic wounds but CTGF protein was dysregulated at the posttranscriptional level. In diabetic wounds involving skin and subcutaneous tissues, growth factors, such as PDGF and VEGF protein, that are normally induced in solid organs in diabetes have been reported to be present in reduced amount in wounds [6, 7] . The cause of the difference in growth factor findings across tissues in diabetes is unclear, although it may be due to the prolonged inflammatory and protease state that characterises diabetic wounds [39] compared with the profibrotic environment that predominates in diabetic nephropathy [21] .
In summary, this model demonstrates that wound healing is delayed in diabetic baboons. Inflammatory cell induction is abnormal, granulation tissue is impaired and CTGF is not present in tissue in usual amounts. Interventions in the model can now be undertaken to determine whether wound healing in diabetes can be improved and possibly normalised.
